series-c-plus
Stage
1
Investors
About
Solid Biosciences is a biotechnology company developing gene therapy candidates for rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy, Friedreich’s ataxia, and catecholaminergic polymorphic ventricular tachycardia.
Explore Solid Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.